ANVS Other: a positive outcome, +10.8%

On October 30, 2026, Annovis Bio, Inc. reached its Other. The result was a positive outcome, and the stock moved +10.8% in the window around the event. It had already run -21.3% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.